Gastroenterology

publication venue for

Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease. 2020
A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease. 2018
Painful Anterior Chest Wall Mass, Compatible With Abscess on Computed Tomography and Possible Osteomyelitis in a Man With Ulcerative Colitis. 2016
Endoscopic ultrasonography-guided jejunojejunostomy to facilitate endoscopic retrograde cholangiopancreatography: a minimally invasive option. 2014
Internal EUS-directed transgastric ERCP (EDGE): game over. 2014
Electronic clinical challenges and images in GI. Image 1. 2008
Image of the month. Echinococcal cyst of the liver. 1999
Mast cell cholangiopathy: another cause of sclerosing cholangitis. 1995
The Educational Impact of the GI Hospitalist Model on Gastroenterology Fellowship Training. 2024
Treating Chronic Pancreatitis Pain using Extracorporeal Shock-Wave Lithotripsy and Endoscopy. 2024
Validation of an Electronic Health Record-Based Machine Learning Model Compared With Clinical Risk Scores for Gastrointestinal Bleeding. 2024
Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis. 2024
Benefits of NSAIDs plus Pancreatic Stenting to Prevent Post-ERCP Pancreatitis. 2024
A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study. 2024
Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. 2024
Clinical Applications of Endoscopic Bariatric Therapies: Potential and Pitfalls. 2023
Trends in Medicare Spending on Oral Medications for Hepatitis B from 2013 to 2020. 2023
Cold Snare Polypectomy for Small Colo-rectal Polyps-Quick and Safe. 2023
"Enhancing Nutrition and Obesity Education in GI Fellowship through Universal Curriculum Development". 2023
Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test.. 165. 2023
Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.. 164. 2022
Treatment of Women With Hepatitis C Diagnosed in Pregnancy: a Co-Located Treatment Approach.. 163. 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. 2022
Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States From 2014 to 2020.. 163. 2022
Databases for Gastrointestinal Clinical and Public Health Research: Have Database, Will Research.. 163. 2022
AGA Institute Quality Measure Development for Intragastric Balloons in the Management of Obesity. 2022
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.. 162. 2021
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model. 2021
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.. 161. 2021
The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature.. 161. 2021
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.. 161. 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.. 160. 2021
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.. 160. 2021
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.. 160. 2020
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.. 160. 2020
Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.. 159. 2020
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.. 159. 2020
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.. 159. 2020
Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.. 159. 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.. 158. 2020
Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men.. 158. 2020
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.. 158. 2019
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer.. 158. 2019
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.. 158. 2019
Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.. 157. 2019
Endoscopic Surveillance of Barrett's Esophagus Using Volumetric Laser Endomicroscopy With Artificial Intelligence Image Enhancement.. 157. 2019
Promoting Leadership by Women in Gastroenterology-Lessons Learned and Future Directions.. 156. 2019
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.. 156. 2019
Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.. 156. 2018
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.. 155. 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.. 155. 2018
Diet Modifies Colonic Microbiota and CD4⁺ T-Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-Cell Expression of Interleukin 23.. 155. 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.. 155. 2018
Older Age Reduces Upper Esophageal Sphincter and Esophageal Body Responses to Simulated Slow and Ultraslow Reflux Events and Post-Reflux Residue.. 155. 2018
Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.. 155. 2018
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.. 155. 2018
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.. 154. 2017
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.. 153. 2017
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.. 152. 2017
American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease.. 152. 2017
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.. 151. 2016
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.. 151. 2016
The Intestinal Microenvironment and Functional Gastrointestinal Disorders. 2016
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.. 150. 2015
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.. 150. 2015
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.. 149. 2015
A combination of molecular markers and clinical features improve the classification of pancreatic cysts.. 149. 2015
Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.. 149. 2015
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.. 149. 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.. 149. 2015
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.. 148. 2014
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.. 148. 2014
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.. 147. 2014
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.. 146. 2013
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.. 145. 2013
A novel submucosal gel permits simple and efficient gastric endoscopic submucosal dissection.. 144. 2013
Crypt base columnar stem cells in small intestines of mice are radioresistant.. 143. 2012
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.. 143. 2012
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.. 142. 2012
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.. 142. 2012
Hepatitis C virus infects the endothelial cells of the blood-brain barrier.. 142. 2011
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.. 141. 2011
Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.. 141. 2011
TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis.. 141. 2011
Survivors of childhood cancer have increased risk of gastrointestinal complications later in life.. 140. 2011
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.. 140. 2011
Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.. 140. 2010
Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.. 140. 2010
Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer.. 138. 2010
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.. 139. 2010
Report of the multisociety task force on GI training.. 137. 2009
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury.. 137. 2009
Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.. 137. 2009
Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.. 137. 2009
Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.. 136. 2009
Clinical staging and survival in refractory celiac disease: a single center experience.. 136. 2008
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.. 135. 2008
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.. 135. 2008
Donor morbidity after living donation for liver transplantation.. 135. 2008
Improvement in survival associated with adult-to-adult living donor liver transplantation.. 133. 2007
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.. 133. 2007
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.. 131. 2006
Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.. 131. 2006
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection.. 131. 2006
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.. 131. 2006
Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways.. 130. 2006
In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta.. 128. 2005
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.. 128. 2005
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.. 128. 2005
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.. 127. 2004
Profiling of microdissected gastric epithelial cells reveals a cell type-specific response to Helicobacter pylori infection.. 127. 2004
Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery.. 126. 2004
Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial.. 125. 2003
Gastric electrical stimulation for medically refractory gastroparesis.. 125. 2003
Hepatitis B virus genotypes in the United States: results of a nationwide study.. 125. 2003
Training the gastroenterologist of the future: the Gastroenterology Core Curriculum.. 124. 2003
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.. 122. 2002
Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.. 122. 2002
Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids.. 121. 2001
Neural stem cells express RET, produce nitric oxide, and survive transplantation in the gastrointestinal tract.. 121. 2001
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.. 120. 2001
Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.. 120. 2001
Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration.. 119. 2000
Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.. 119. 2000
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.. 116. 1999
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.. 115. 1998
Consequences of Fas-ligand and perforin expression by colon T cells in a mouse model of inflammatory bowel disease.. 115. 1998
Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection.. 115. 1998
Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial.. 115. 1998
Pancreatic thread protein is mitogenic to pancreatic-derived cells in culture.. 110. 1996
Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States.. 109. 1995
Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder.. 106. 1994
The motor response to intestinal resection: motor activity in the canine small intestine following distal resection.. 105. 1993
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.. 105. 1993
Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock.. 104. 1993
Localization of islet cell tumors by endoscopic ultrasonography.. 103. 1992
Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure.. 102. 1992
Familial adenomatous polyposis and colorectal cancer: one gene or two genes?. 102. 1992
Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins.. 102. 1992
Primary sclerosing cholangitis: is medical therapy on the way?. 102. 1992
The p53 gene and hepatocellular carcinoma.. 101. 1991
Colon cancer and the p53 oncogene.. 100. 1991
Small intestinal transit in the portal hypertensive rat.. 100. 1991
Surveillance after colon cancer: is it worthwhile?. 99. 1990
Familial pancreatic cancer: insight into etiology or an interesting quirk of nature?. 99. 1990
The clogged biliary endoprosthesis: help on the way.. 99. 1990
Infrequent point mutations of ras oncogenes in gastric cancers.. 98. 1990
Look at the duodenum in familial polyposis.. 98. 1990
Ampullary neoplasia: an endoscopic approach.. 98. 1990
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.. 97. 1989
Multiple primary malignant tumors.. 93. 1987
pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients.. 92. 1987
Cancer family syndrome: marker studies.. 91. 1986
Apparent complete lower esophageal sphincter relaxation in achalasia.. 90. 1986
Hepatitis in children with acquired immune deficiency syndrome. Histopathologic and immunocytologic features.. 90. 1986
Effects of morphine and atropine on motility and transit in the human ileum.. 89. 1985
Distinctive patterns of interdigestive motility at the canine ileocolonic junction.. 87. 1984
Motility of the terminal ileum and ileocecal sphincter in healthy humans.. 87. 1984
Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.. 86. 1984
Myoelectric activity and intraluminal pressure of the canine ileocolonic sphincter.. 85. 1983
Copper metabolism and requirements in total parenteral nutrition.. 81. 1981
Pharmacological protection against swine stress ulcer.. 66. 1974
Lipolysis and absorption of fat in the rat stomach.. 56. 1969
Enzyme induction in the liver.. 55. 1968
Ranitidine Use and Cancer Risk: Results From UK Biobank.. 160. 2020
Peppermint Oil in Irritable Bowel Syndrome.. 159. 2020
Reply.. 157. 2019
Reply.. 150. 2016
Reply.. 150. 2015
Fecal transplantation: beyond the aesthetic.. 145. 2013
The microbiota and bariatric surgery: it's a bug's life.. 142. 2011
Doxorubicin and sorafenib for treatment of advanced hepatocellular cancer.. 141. 2011
Antibiotics for irritable bowel syndrome: hitting the target, but what is it?. 141. 2011
Functional dyspepsia: eosinophils, macrophages, and the postinfectious state.. 140. 2011
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice.. 138. 2009
A serologic test for irritable bowel syndrome: real meat or bare bones?. 137. 2009
Gut permeability in irritable bowel syndrome: more leaks add to slightly inflamed bowel syndrome conspiracy theory.. 137. 2009
More rare birds, and the occasional swan.. 136. 2009
Small bowel imaging for Crohn's disease: camera, contrast, or scope?. 136. 2009
Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome.. 129. 2005
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.. 129. 2005
Gastric electrical stimulation for refractory gastroparesis.. 126. 2004
Bad bile in the esophagus: gastroesophageal reflux or duodenogastric reflux?. 110. 1996
Galactose clearance and hepatic blood flow.. 96. 1989
An association of fecal bile acids and colon cancer in ulcerative colitis?. 95. 1988
Microscopic and collagenous colitis: different names for the same condition?. 91. 1986
Liver biopsy septicemia.. 73. 1977
Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis.. 72. 1977
Endoscopic Sleeve Gastroplasty Results in Higher Weight Loss Compared With Lifestyle Modifications Alone. 2022
Endoscopic balloon dilation: the panacea for Crohn's strictures? 2010
To drain or not to drain: that is the question. 2010
Reply to Congly et al. 2023
Comment Regarding "Gallstones, Cholecystectomy, and Kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts". 2023
Reply. 2022
Mentoring Disparities in Gastroenterology: The Path Forward. 2021
Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous With Injury or Noise? 2020
Reply: To PMID 24975458. 2015
High-dose omeprazole in patients with noncardiac chest pain. 1999
No demonstration of gallbladder motility disorder. 1987
Report from the multinational irritable bowel syndrome initiative 2012. 2013
The Proton Pump Inhibitor Is Not Working: Assess Don't Guess.. 160. 2020
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum.. 159. 2020
Incidence of Colorectal Cancer Matters.. 158. 2019
Getting into a TIF(F) Over Fundoplication.. 154. 2018
Irritable Bowel Syndrome: An Infectious Disease?. 152. 2017
Constipation and the Microbiome: Lumen Versus Mucosa!. 150. 2015
Endoscopic therapies for gastroesophageal reflux disease: back in the game?. 148. 2014
Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis.. 147. 2014
Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fiction.. 145. 2013
Interleukin-23: linking mesenteric lymph node dendritic cells with Th1 immunity in Crohn's disease.. 137. 2009
Cholelithiasis plus choledocholithiasis: ERCP first, what next?. 130. 2006
Functional gastrointestinal disease: has the genomic era arrived?. 126. 2004
Hepatitis C virus replicons finally get to second base.. 125. 2003
MELD and the practicing gastroenterologist.. 125. 2003
The acid suppression test for unexplained chest pain.. 115. 1998
The clinical pharmacology of motility disorders: the perils (and pearls) of prokinesia.. 106. 1994
Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases. 2020
Hepatobiliary complications of total parenteral nutrition. 1993
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. 2022
Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. 2017
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. 2015
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. 2022

VIVO Weill Cornell Medical College

Gastroenterology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)